SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer
Titel:
SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer
Auteur:
Livingston, Robert B. Barlow, William E. Kash, Joseph J. Albain, Kathy S. Gralow, Julie R. Lew, Danika L. Flaherty, Lawrence E. Royce, Melanie E. Hortobagyi, Gabriel N.